Viewing Study NCT04508751



Ignite Creation Date: 2024-05-06 @ 3:03 PM
Last Modification Date: 2024-10-26 @ 1:42 PM
Study NCT ID: NCT04508751
Status: COMPLETED
Last Update Posted: 2023-08-30
First Post: 2020-08-03

Brief Title: PED NEONAT 20-000599 Fetal Body Composition
Sponsor: University of California Los Angeles
Organization: University of California Los Angeles

Study Overview

Official Title: Fetal Body Composition and Free-Breathing Magnetic Resonance Imaging
Status: COMPLETED
Status Verified Date: 2022-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Obesity is an ongoing public health problem that is difficult to treat There is evidence that obesity has fetal origins Body composition including visceral subcutaneous brown and hepatic fat have been found to be important predictors in obesity and metabolic syndrome Magnetic resonance imaging MRI can quantify body composition that does not require radiation but is motion limited The investigators have developed a motion-compensated MRI sequence also known as free breathing MRI In this study the investigators plan to obtain free-breathing MRIs of pregnant women in the third trimester of pregnancy MRIs will be obtained from healthy mothers mothers with growth-restricted fetuses and mothers with gestational diabetes The different types of adipose tissue will be measured and compared between groups and correlated to birth growth parameters The goal is this study is to assess if motion-compensated MRI can help predict early growth patterns in infancy
Detailed Description: 11 OBJECTIVE This studys goals are to 1 use free-breathing magnetic resonance imaging FB-MRI to measure fetal body composition in the third trimester and 2 determine how the FB-MRI quantitative measurements compare to growth parameters at birth

12 HYPOTHESES AND SPECIFIC AIMS

To accomplish the investigators objectives the aims and hypotheses are as follows

Specific Aim 1

In a prospective study in women with healthy pregnancies and women with fetuses that have intrauterine growth restriction IUGR and gestational diabetes the investigators will quantify fetal subcutaneous visceral and brown adipose tissue volumes and proton-density fat fraction PDFF using FB-MRI in the third trimester

Hypothesis 1 Using a FB-MRI technique the investigators will find the following

1 The growth-restricted fetus will have less visceral subcutaneous and brown adipose tissue volume and PDFF when compared to healthy fetuses and fetuses whose mothers have gestational diabetes
2 Fetuses whose mothers have gestational diabetes will have a greater subcutaneous and visceral adipose tissue volume and PDFF compared to healthy fetuses

Specific Aim 2

In a prospective study in pregnant women and their fetuses the investigators will compare volume and PDFF measurements of fetal visceral subcutaneous and brown adipose tissue obtained with FB-MRI to birth growth parameters of these infants

Hypothesis 2 The volume and PDFF of fetal visceral and subcutaneous adipose tissue will correlate positively with birth weight and length z-score

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None